Simplex Trading, LLC Corbus Pharmaceuticals Holdings, Inc. Transaction History

Simplex Trading, LLC

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 02, 2022	SELL	$0.32 - $0.67 $9,585 - $20,069	-29,954 Closed	0 $0
Q4 2021 Feb 23, 2022	SELL	$0.6 - $1.11 $40,702 - $75,299	-67,837 Reduced 69.37%	29,954 $18,000
Q3 2021 Oct 28, 2021	SELL	$1.01 - $1.82 $15,786 - $28,446	-15,630 Reduced 13.78%	97,791 $177,000
Q2 2021 Aug 12, 2021	BUY	$1.39 - $2.21 $121,907 - $193,823	87,703 Added 341.02%	113,421 $207,000
Q1 2021 Apr 26, 2021	SELL	$1.27 - $3.42 $54,900 - $147,843	-43,229 Reduced 62.7%	25,718 $50,000
Q4 2020 Feb 02, 2021	SELL	$0.94 - $1.89 $189,951 - $381,923	-202,076 Reduced 74.56%	68,947 $86,000
Q3 2020 Oct 14, 2020	BUY	$1.5 - $9.38 $264,567 - $1.65 Million	176,378 Added 186.36%	271,023 $487,000
Q2 2020 Jul 13, 2020	BUY	$4.79 - $8.39 $425,174 - $744,721	88,763 Added 1509.06%	94,645 $794,000
Q1 2020 Apr 29, 2020	SELL	$3.44 - $7.21 $49,618 - $103,997	-14,424 Reduced 71.03%	5,882 $30,000
Q4 2019 Feb 05, 2020	BUY	$4.29 - $5.64 $87,112 - $114,525	20,306 New	20,306 $110,000
Q1 2019 Apr 18, 2019	SELL	$5.76 - $8.95 $109,244 - $169,745	-18,966 Closed	0 $0
Q4 2018 Jan 16, 2019	SELL	$5.26 - $7.97 $23,438 - $35,514	-4,456 Reduced 19.02%	18,966 $110,000
Q3 2018 Oct 23, 2018	BUY	$4.65 - $7.95 $108,912 - $186,204	23,422 New	23,422 $176,000
Q2 2018 Jul 30, 2018	SELL	$5.05 - $6.8 $7,489 - $10,084	-1,483 Closed	0 $0
Q1 2018 Apr 26, 2018	SELL	$5.6 - $9.25 $86,956 - $143,634	-15,528 Reduced 91.28%	1,483 $9,000
Q4 2017 Jan 10, 2018	BUY	$6.6 - $7.78 $112,272 - $132,345	17,011	17,011 $120,000

38.7K

Ticker CRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,268,000
Market Cap $2.08B
Description
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.